Your browser doesn't support javascript.
loading
Response to Letter to the Editor From Virú-Loza and Chávez-Nomberto: "Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort".
Maghnie, Mohamad; Ranke, Michael B; Geffner, Mitchell E; Vlachopapadopoulou, Elpis; Ibáñez, Lourdes; Carlsson, Martin; Cutfield, Wayne; Rooman, Raoul; Gomez, Roy; Wajnrajch, Michael P; Linglart, Agnès; Stawerska, Renata; Clayton, Peter E; Darendeliler, Feyza; Hokken-Koelega, Anita C S; Horikawa, Reiko; Tanaka, Toshiaki; Dörr, Helmuth-Günther; Albertsson-Wikland, Kerstin; Polak, Michel; Grimberg, Adda.
Affiliation
  • Maghnie M; Department of Pediatrics, IRCCS Giannina Gaslini, Genova 16124, Italy.
  • Ranke MB; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health - DINOGMI, University of Genova, Genova 16124, Italy.
  • Geffner ME; Department of Pediatric Endocrinology, University Children´s Hospital, Tübingen 72076, Germany.
  • Vlachopapadopoulou E; The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA 90027, USA.
  • Ibáñez L; Department of Endocrinology, Growth and Development, Aglaia Kyriakou Children's Hospital, Athens 11527, Greece.
  • Carlsson M; Endocrinology, Pediatric Research Institute Sant Joan de Déu, Barcelona 08950, Spain.
  • Cutfield W; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid 28029, Spain.
  • Rooman R; Rare Disease, Biopharmaceuticals, Pfizer, New York, NY 10017, USA.
  • Gomez R; Liggins Institute, University of Auckland, Auckland 1142, New Zealand.
  • Wajnrajch MP; PendoCon, Putte 2580, Belgium.
  • Linglart A; European Medical Affairs, Pfizer, Brussels 1070, Belgium.
  • Stawerska R; Rare Disease, Biopharmaceuticals, Pfizer, New York, NY 10017, USA.
  • Clayton PE; Department of Pediatrics, New York University Langone Medical Center, New York, NY 10016, USA.
  • Darendeliler F; Department of Pediatric Endocrinology and Diabetology for Children, AP-HP, Bicêtre Paris Saclay, Le Kremlin Bicêtre 94270, France.
  • Hokken-Koelega ACS; APHP, Reference Center for Rare Disorders of the Calcium and Phosphate Metabolism, Filière OSCAR and Plateforme d'Expertise Maladies Rares Paris-Sud, Bicêtre Paris Saclay Hospital, Le Kremlin Bicêtre 94270, France.
  • Horikawa R; Department of Endocrinology and Metabolic Diseases, Polish Mother's Memorial Hospital-Research Institute, Lodz 93-338, Poland.
  • Tanaka T; Department of Pediatric Endocrinology, Medical University of Lodz, Lodz 93-338, Poland.
  • Dörr HG; Developmental Biology and Medicine, Faculty of Biology Medicine and Health, Manchester NIHR Academic Health Science Centre, University of Manchester, Manchester M13 9PL, UK.
  • Albertsson-Wikland K; Istanbul University, Istanbul Faculty of Medicine, Pediatric Endocrinology Unit, Istanbul 34452, Turkey.
  • Polak M; Pediatrics, Subdivision of Endocrinology, Erasmus University Medical Center, Rotterdam 3015 GD, the Netherlands.
  • Grimberg A; Division of Endocrinology and Metabolism, National Center for Child Health and Development, Tokyo 157-8535, Japan.
J Clin Endocrinol Metab ; 108(6): e356-e357, 2023 05 17.
Article de En | MEDLINE | ID: mdl-36721915

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Hormone de croissance / Hormone de croissance humaine Limites: Child / Humans Langue: En Journal: J Clin Endocrinol Metab Année: 2023 Type de document: Article Pays d'affiliation: Italie Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Hormone de croissance / Hormone de croissance humaine Limites: Child / Humans Langue: En Journal: J Clin Endocrinol Metab Année: 2023 Type de document: Article Pays d'affiliation: Italie Pays de publication: États-Unis d'Amérique